(Q35682391)

9 August 2017

title

Diagnostic value of progesterone receptor and p53 expression in uterine smooth muscle tumors (English)

1 reference

9 August 2017

Iman H Hewedi

1

1 reference

9 August 2017

Nehal A Radwan

series ordinal

2

1 reference

9 August 2017

Lobna S Shash

series ordinal

3

1 reference

9 August 2017

publication date

5 January 2012

1 reference

9 August 2017

1 reference

9 August 2017

volume

7

1 reference

9 August 2017

page(s)

1

1 reference

Creative Commons Attribution 2.0 Generic

9 August 2017

copyright license

start time

5 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Benign metastasizing leiomyoma of the uterus: documentation of clinical, immunohistochemical and lectin-histochemical data of ten cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261803

Uterine leiomyomata: etiology, symptomatology, and management.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261803

Differential expression of P16 and P21 in benign and malignant uterine smooth muscle tumors.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261803

Expression of Ki-67, P53 and progesterone receptors in uterine smooth muscle tumors. Diagnostic value.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261803

Uterine leiomyoma versus leiomyosarcoma: a new attempt at differential diagnosis based on their cellular characteristics.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261803

The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261803

Differential diagnosis of smooth muscle tumors utilizing p53, pTEN and Ki-67 expression with estrogen and progesterone receptors.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261803

Estrogen and progesterone receptor expression in patients with uterine smooth muscle tumors

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261803

Estrogen and progesterone receptor expression in patients with uterine leiomyosarcoma and correlation with different clinicopathological parameters.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261803

MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261803

Expression of angiogenic factors and apoptotic factors in leiomyosarcoma and leiomyoma

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261803

Immunohistochemical analysis of p53 protein in uterine sarcomas

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261803

Comparison of cytosolic p53 protein levels in the female genital tract and breast, and their tumors

25 September 2018

1 reference

12 December 2020

Cytoplasmic estrogen and progesterone receptor content of uterine sarcomas

1 reference

12 December 2020

Mitotic activity in uterine leiomyomas during the menstrual cycle

1 reference

12 December 2020

p53 alterations in uterine leiomyosarcomas versus leiomyomas

1 reference

12 December 2020

p53 immunoreactivity and mutation of the p53 gene in smooth muscle tumours of the uterine corpus

1 reference

12 December 2020

[Smooth muscle neoplasms of the uterus--a 51 cases study]

1 reference

12 December 2020

Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas

1 reference

12 December 2020

Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases

1 reference

12 December 2020

[Uterine smooth muscle tumors: retrospective epidemiological and pathological study of 2760 cases]

1 reference

12 December 2020

Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential

1 reference

12 December 2020

Identifiers

DOI

10.1186/1746-1596-7-1

1 reference

Dimensions Publication ID

9 August 2017

0 references

1 reference

9 August 2017

1 reference